sur Medicure, Inc. (NASDAQ:MCUJF)
Medicure Reaches Settlement in Product Development and Supply Contract
Medicure Inc., a pharmaceutical company based in Winnipeg, Manitoba, has successfully reached a settlement regarding a product development and supply contract. This settlement involves its subsidiaries, Medicure International Inc. and Medicure Pharma Inc., alongside a third party whose identity remains undisclosed.
As part of the settlement agreement, Medicure received a payment of €1.5 million. While the terms of the settlement have not been fully disclosed, the company has emphasized its commitment to resolving contractual matters efficiently.
Medicure continues to focus on developing and commercializing healthcare products in the United States, notably AGGRASTAT® and ZYPITAMAG®, through its U.S. subsidiary, Medicure Pharma Inc.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Medicure, Inc.